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Objectives: Increased arterial stiffness is a risk factor of atherosclerosis and cardio-vascular complications. The aim
of the study was to determine whether peripheral vascular function might be an early marker of impaired health
status in patients with a single ventricle after Fontan procedure.
Methods and results: Twenty five consecutive adults (11 women and 14 men) aged 24.7 ± 6.2 years after the
Fontan procedure and 25 sex, age and BMI match healthy volunteers underwent physical examination, blood
analysis, transthoracic echocardiography and noninvasive assessment of aortic stiffness. Augmented pressure and
Augmentation Index (AIx) were both significantly elevated in Fontan when compared to the controls (6,08 ± 0,7 vs.
2,0 ± 3,7; p = 0.002 and 17,01 ± 3,3 vs. 6,05 ± 11; p < 0.001, respectively). There were no differences in pulse wave
velocity (PWV), mean blood pressure (BP), brachial pulse pressure (PP), central: systolic BP, diastolic BP and PP. In
Fontan group we find negative correlation between PWV and SatO2 (r = −0.68; p = 0.04) and positive correlation
with WBC (0.72; p = 0.72; p = 0.013), INR (0.81; p = 0.008), TNFα (r = 0.45; p = 0.04), and postoperative time (r = 0.77;
p = 0.02). AIx correlates positively only with age at surgery (r = 0.45; p = 0.04). Bilirubin level correlates positively with
brachial PP (r = 0.71; p = 0.02) and central PP (r = 0.68; p = 0.03).
The multivariate model showed that SatO2 (β = −0.44, p = 0.04) was the only independent predictor of PWV
(R2 = 0.32, p = 0.03).
Conclusion: Adult Fontan patients have an increased arterial stiffness assessed by a noninvasive technique.
Low arterial oxygen saturation postoperative time, age at surgery, white blood cells, TNFα and bilirubin level are
associated with arterial stiffening in these patients. The combination of blood parameters of the hepatic function
and noninvasive measurements of arterial stiffness could be helpful in comprehensive care of patients with Fontan
circulation.
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Non-invasive measurement of vascular parameters is in-
creasingly used to assess the risk of cardiovascular disease.
It is considered that the loss of elasticity of the walls of the
arteries, especially the aorta is a marker of the early changes
that may lead to the development of atherosclerosis and its
following complications (eg, hypertension, stroke, myocar-
dial infarction) in healthy individuals [1]. Increase in arterial
stiffness was proven to be caused by several factors such
as age, hypertension, hypercholesterolemia, diabetes, and* Correspondence: ltom@wp.pl
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article, unless otherwise stated.smoking [2-5]. In the detection of early growth of the aortic
wall stiffness pulse wave velocity (PWV) and/or augmenta-
tion index (AIx) are commonly used [6].
Fontan operation is a widely used method of treatment
of patients with single ventricle. The main goal of this
procedure is the separation of the pulmonary and sys-
temic circulation. The treatment is multistage and it re-
sults in the absence of subpulmonary ventricle. The
blood flow through the lungs is effected due to the pres-
sure gradient between the systemic veins and the left
atrium and has non-pulsatile character [7,8].
A vast majority of the patients born with a functional
single ventricle, who underwent Fontan surgery in early
childhood, survive over 20 years [9]. The longer the timeed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 The pulse waveform in the ascending aorta. P1 - the
first systolic peak caused by the force of myocardial contraction,
P2 - the second peak caused by pulse wave reflected returning from
the periphery to the heart, AP (AP = P1 - P2) - augmented pressure,
PP - (pulse pressure).
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tions are noted [8,9]. Thus patients are at high risk of
mortality and morbidity. The development of impaired
functional health status is caused by reduced cardiac
output, increased systemic vascular resistance, ventricu-
lar dysfunction, arrhythmia, and heart failure [7-10].
The present study was designed to evaluate the useful-
ness of the noninvasive measurement of arterial stiffness
to determine whether peripheral vascular function might
be an early marker of impaired health status in patients
with a single ventricle after Fontan procedure. We also
evaluated the impact of endothelial dysfunction and
inflammation on parameters of arterial stiffness.
Material and methods
Study population
The patients were recruited consecutively at the John
Paul II Hospital in Krakow and enrolled into the study if
they had had the Fontan operation, were ≥18 years old,
and were clinically stable for at least 3 months before
the study.
The patients underwent physical examination, blood
analysis, transthoracic echocardiography and noninva-
sive assessment of aortic stiffness. Medical histories were
taken and they included demographic, anatomic data,
previous interventions and medical therapy. The exclu-
sion criteria were: arrhythmia, any acute illness, cancer,
diabetes mellitus, hypertension, acute vascular event, al-
cohol abuse and pregnancy.
Healthy subjects were not on any medication and had
no history of cardiovascular or cerebrovascular disease.
The institutional ethics committee approved the study
protocol. All the participants signed informed consent
before enrolling into the study.
Arterial stiffness
Assessment of the central hemodynamic data and aortic
stiffness was performed by non-invasive examination of
the peripheral arteries. Measurements were performed
after 8 hours fasting, before medications, in the supine
position, in a quiet room, with an air temperature of
22 ± 1°C [6]. Shortly before the test arterial blood pres-
sure (BP) and heart rate were measured with use of an
automatic sphygmomanometer OMRON M6. Tests were
performed by applanation tonometry by SphygmoCor ®
(ATCOR Medical, Sidney, Australia). In order to mea-
sure PWV the applanation tonometer was applied at first
to the common carotid artery, then to the femoral. The
measurements were performed independently of each
other but with respect electrocardiography (ECG) regis-
tered at the same time.
Central: systolic BP, diastolic BP, pulse pressure (PP),
augmented pressure (AP) and augmetation Index (AIx)
were obtained during the course of at least 12 secondsregistration of the pulse wave graph at the radial artery
and calculated by a validated generalized transfer function.
AP is a parameter that determines the difference be-
tween the peak of the reflected wave from the periphery
(P2) and the peak of the wave generated by the contrac-
tion of the left ventricle (P1) (AP = P2 - P1 [mmHg]).
AP describes the increase or decrease in the amount of
pulse wave in the ascending aorta in relation to strength-
ening it by the wave returning from the periphery to the
ascending aorta (Figure 1).
AIx is expressed as the ratio of the augmented pres-
sure (AP) and PP in the aorta. (AIx = AP/PP [%]), and
speaks of the percentage change (increase or decrease)
of the pressure in the aorta (pulse wave height) under
the influence of the peripheral wave and it is dependent
on the duration of the cardiac cycle, PWV in the vessels
and the amplitude of the reflected wave. Because the
value of AIx is influenced by heart rate, AIx was stan-
dardized for the heart rate of 75/min [11].
Single ventricle ejection fraction (SVEF) was assessed by
echocardiography (Vivid 7 GE Medical System, USA) using
a Simpson method. Oxygen saturation (SatO2) was mea-
sured noninvasively by pulse oximeter in room air
Laboratory measurements
Blood samples from a peripheral vein were drawn into
tubes. All blood samples were obtained in the morning
after an overnight fast. In patients using warfin, blood was
drawn at least 5 days after drug withdrawal. Plasma levels
of white blood cells (WBC), platelet count, red blood
cells (RBC), hematocrit (HCT), hemoglobin (Hg), total
protein, alanine aminotransferase (ALT), C-reactive protein
(CRP), creatinine, bilirubin, gamma glutamylo transpepti-
daza (GGTP) international normalized ratio (INR), N-
terminal pro-B-type natriuretic peptide (NT-pro-BNP)
were assayed by routine laboratory techniques.
Table 1 Study population characteristic
Fontan (n = 25) Healthy (n = 25) p=
Age, years 24.7 ± 6.2 26.9 ± 3.4 0.14
Sex 14 M / 11 F 15 M / 10 F 0.4
BMI, kg/m2 21,7 ± 2 22,56 ± 3 0.3
SBP, mmHg 127.2 ± 13.9 124 ± 10.6 0.42
DBP, mmHg 79.4 ± 7.3 77.7 ± 5.2 0.32
HR, BPM 64.8 ± 12.6 68.9 ± 16.2 0.33
SatO2,% 88.5 ± 6.8 96.9 ± 1.6 <0.001
SVEF,% 51.6 ± 5.4 69.3 ± 1.6 <0.001
BMI-body mass index, SBP-systolic blood pressure, DBP- diastolic blood pres-
sure, HR- heart rate, SatO2 – arterial saturation, SVEF – single ventricle
ejection fraction.
Table 2 Laboratory characteristics of Fontan patients
and controls
Variable Fontan (n = 25) Controls (n = 25) p
WBC, 103/μl 5.2 ± 1.6 5.9 ± 1.4 0.1
RBC, 109/μl 6.2 ± 2.5 4.8 ± 0.5 <0.001
Hg, g/dl 16.8 ± 1.4 14.1 ± 1.3 <0.001
HCT,% 49.1 ± 3.3 42.2 ± 3.3 p < 0.001
Platelet count, 103/μl 127.8 ± 33.8 228.1 ± 50.6 <0.001
Total protein, g/dl 75.9 ± 4.9 73.9 ± 2.5 0.08
GGTP, U/L 87.3 ± 50.5 17.8 ± 8.3 <0.001
ALT, IU/l 30.9 ± 11.9 21.3 ± 6.2 <0.001
Bilirubin, μmol/l 23.7 ± 16.3 8.1 ± 3.8 <0.001
INR, 1.2 ± 0.2 1 ± 0.1 <0.001
TNFα, pg/ml 7.1 ± 1.5 2.4 ± 1.2 <0.001
CRP, mg/l 2.6 ± 2.7 1.9 ± 1.7 0.6
Endthelin-1, pg/ml 2.5 ± 0.1 1.3 ± 0.05 0.002
NTpro-BNP 302.3 ± 601.8 72.2 ± 45.9 <0.001
WBC- white blood cells, RBC - red blood cells, Hg – hemoglobin, HCT- hematocrit,
GGTP – gammaglutamylo transpeptydaza, ALT - alanine aminotransferase,
INR - international normalized ratio, TNFα – tumor necrosis factor alfa,
CRP - C-reactive protein, NT-pro-BNP- N-terminal pro-B-type natriuretic peptide.
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(TNFα) were determined by the ELISA method (R&D
Systems).
Statistical analysis
Continuous variables are expressed as mean ± SD. Cat-
egorical variables are described as counts and percent-
ages. Patients after Fontan operation and controls were
compared with the Mann Whitney U-test for the con-
tinuous variables and with the chi square test for cat-
egorical variables. Correlations between the individual
parameters were calculated using the Spearman rank
test. Factors that determine PWV were analyzed using
multiple logistic regression. A p-value <0.05 was consid-
ered statistically significant. The statistical analyses were
performed with the PQ Stat version 1.4.2.324 software.
Results
Group characteristics
Of 35 patients who were assessed for eligibility, 10 subjects
were excluded due to: age below 18 years of life (n = 1),
lack of informed consent (n = 3), and arrhythmias (n = 6).
The study population consisted of: 25 consecutive adults
(11 women and 14 men) aged 24.7 ± 6.2 years who under-
went the Fontan procedure in their childhood and 25 sex,
age and BMI match healthy volunteers. The dominant
cardiac malformation were: tricuspid atresia 12 (48%), pul-
monary atresia with ventricular septal defect and transpos-
ition of great arteries 8 (32% ), double outlet right ventricle
with hypoplasia of left ventricle 2 (8%), double inlet left
ventricle 3 (12%). Modification of the Fontan operation
included direct right atrium-pulmonary artery connection
in 2 (8%) patients and total cavopulmonary connection
(TCPC) by means of intraatrial lateral tunnel in the
remaining 23 (92%) patients. The mean age at Fontan pro-
cedure was 4.6 ± 3.3 years. The mean follow-up time was
20.1 ± 5.2 years. The patients were in NYHA class I 5
(20%), NYHA II 18 (72%) and NYHA III 2 (8%). Six (24%)
patients were treated with warfarin, 1 (4%) with enoksa-
parin, 15 (60%) with aspirin and 3 (12%) were taking in-
hibitor of angiotensin in a small doses. On the day of
examination the patients did not take any medication.
The Fontan patients had lower SVEF (51.6 ± 5.4 vs.
69.3 ± 1.6%; p < 0.001, SatO2 (88.5 ± 6.8 vs. 96.9 ± 1.6%,
p < 0.001) and there were no differences in SBP, DBP,
HR. Study population characteristic is shown in Table 1.
In Fontan group we also find significant higher RBC
(6.2 ± 2.5 vs. 4.8 ± 0.5 109/μl; p < 0.001), Hg (16.8 ±
1.4 vs. 14.1 ± 1.3 g/dl; p < 0.001), HCT (49.1 ± 3.3 vs.
42.2 ± 3.3%; p < 0.001), GGTP (87.3 ± 50.3 vs. 17.8 ±
8.3%; p < 0.001), ALT (30.9 ± 11.9 vs. 21.3 ± 6.2 IU/l; p <
0.001), bilirubin (23.7 ± 16.3 vs. 8.1 ± 3.8 μmol/l; p <
0.001), INR (1.2 ± 0.2 vs. 1 ± 0.1; p < 0.001), TNFα (7.1 ±
1.5 vs. 2.4 ± 1.2 pg/ml; p < 0.001), NT-proBNP (302.3 ±601.8 vs. 72.2 ± 45.9 pg/ml; p < 0.001), endothelin levels
(2.5 ± 0.1 vs. 1.3 ± 0.05 pg/ml; p = 0.002) and signifi-
cantly lower platelet account (127.8 ± 33.8 vs. 228.1 ±
50.6 109/μl; p = <0.001). There were no differences in
WBC, total protein, creatynin and CRP. The results are
shown in Table 2.
Arterial stiffness
Augmented pressure and Augmentation Index were
both significantly elevated in Fontan when compared
to the controls (6.08 ± 0.7 vs. 2.0 ± 3.7; p = 0.002 and
17.01 ± 3.3 vs. 6.05 ± 11; p < 0.001, respectively). There
were no differences in PWV, Mean BP, brachial PP, Central
SBP, Central DBP, Central PP. The results are presented in
Table 3.
Table 3 Arterial stiffness measurements
Fontan (n = 25) Healthy (n = 25) p=
PWV (m/s) 7,81 ± 1,0 7,91 ± 0,8 0.34
AP 6,08 ± 0,7 2,0 ± 3,7 0.002
AIx 17,01 ± 3,3 6,05 ± 11 <0.001
Mean BP, mm Hg 94,5 ± 8,61 92,2 ± 6,9 0,29
PP brachial, mm Hg 47,4 ± 13,8 46,2 ± 11,5 0,74
Central SBP, mm Hg 113,4 ± 12,3 107,9 ± 9,0 0,07
Central DBP, mm Hg 80.4 ± 7,6 78,1 ± 5,4 0,21
Central PP, mm Hg 33,0 ± 10,5 29,8 ± 6,7 0,19
PVW- Pulse Wave Velocity, AP- Augmented Pressure, AIx- Augmentation Index,
BP – blood pressure, PP- pulse pressure, SBP – systolic blood pressure, DBP-
diastolic blood pressure.
Tomkiewicz-Pajak et al. Cardiovascular Ultrasound 2014, 12:15 Page 4 of 6
http://www.cardiovascularultrasound.com/content/12/1/15In Fontan group we find negative correlation between
PWV and SatO2 (r = −0.68; p = 0.04) and positive correl-
ation with WBC (r = 0.72; p = 0.72; p = 0.013), INR (r =
0.81; p = 0.008), TNFα (r = 0.45; p = 0.04), and postopera-
tive time (r = 0.77; p = 0.02). We did not find similar cor-
relation in controls.
Augmentation Index correlates positively only with
age of surgery (r = 0.45; p = 0.04). Bilirubin level corre-
lates positively with PP brachial (r = 0.71; p = 0.02) and
Central PP (r = 0.68; p = 0.03).
To determine the independent effect of clinical and la-
boratory variables, the stepwise regression analysis for
PWV as a dependent variable was performed. The multi-
variate model showed that SatO2 (β = −0.44, p = 0.04)
was the only independent predictor of PWV (R2 = 0.32,
p = 0.03).
Discussion
In the present study of arterial stiffness in patients after
Fontan procedure, we showed increased Augmentation
Index and no difference in Pulse Wave Velocity between
Fontan patients and healthy population. In a healthy car-
diovascular system, the flexible wall of the aorta in-
creases its volume during the systolic ejection of blood
from the left ventricle. This feature prevents excessive
increase in systolic blood pressure. Then, in the diastole
aortic volume it gradually returns to the original size,
ensuring the free flow of blood towards the peripheral
vessels. Pulse wave, created in this way, reaches the dis-
tal parts of the circulatory system, and reflects back to-
wards the heart, reaching the ascending aorta during the
next diastole phase. Its return strengthens the new pulse
wave, causes the increase in diastolic blood pressure,
and provides adequate perfusion of the coronary arteries
[6]. The aorta acts as a conduit and a cushion for pulsate
flow of the blood, and any stiffening of its wall results in
faster propagation of the blood (i.e., increased PWV).
Arterial stiffness represents the load against which the
left ventricle must eject its volume.Arterial stiffness may be evaluated in any part of the
arterial system. However, the process of stiffening that
occurs in the walls of the aorta is the one of the primary
interest [6]. In literature there is evidence that increased
arterial stiffness is an independent predictor of morbidity
and mortality in patients with cardiovascular diseases as
well as in healthy individuals [12-16].
The idea that the biophysical properties of the aorta
are abnormal in a population of patients with Fontan
circulation has been recently studied by Myers at al [17].
Their research showed that Fontan patients had faster
PWV, implying stiffer arteries and abnormal arterial
health. They concluded that increased arterial stiffness is
an additional factor responsible for the development of
late ventricular failure in patients with single ventricles.
Our data are similar to the results of Lambert et al.
[18]. The authors not only showed the increased arterial
stiffness comparing to healthy controls, but also demon-
strated that Fontan patients have increased muscle sym-
pathetic nerve activity and impaired endothelial function
too. They postulated that monitoring the development
of the increased arterial stiffness along with clinical out-
comes may help in delay of the inevitable diastolic dys-
function of the Fontan patients’ heart.
The mechanism leading to an increased arterial stiff-
ness in Fontan patients is difficult to define. It was
proven that parameters of the arterial stiffness are under
the influence of age [17]. The results of our study do not
confirm the relationship between abnormal arterial stiff-
ness and patients age. Moreover, we find association be-
tween parameters of arterial stiffness and postoperative
time in patients with Fontan circulation. There is evi-
dence that majority of complications appear late after
Fontan procedure [8,10]. We also find association be-
tween augmentation index and age at surgery. The re-
sults are not surprising, given the fact that before the
surgery, chronic cyanosis and volume overloading may
contribute to arterial stiffness [7].
Our study demonstrated that arterial oxygen saturation
is an important determinant of arterial stiffness in adult
Fontan patients. To our knowledge there was no research
in this area. However, the problem was discussed in litera-
ture concerning patients with sleep-disordered breathing
as well as in patients with chronic obstructive pulmonary
disease (COPD). The authors [19,20] found that nocturnal
O2 desaturation caused by sleep apnea is associated with
increased PWV among normotensive and hypertensive in-
dividuals. Cinarka et al. [21] not only showed that hypox-
emia affects arterial stiffness, but also proved that PWV is
faster in patients with severe COPD than in patients with
milder forms of this disease.
Previous study showed that arterial oxygen saturation
decreased in majority of adult Fontan patients [8]. The
reason of this phenomena is multifactorial and may result
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tion, a rise in pulmonary pressure and right-to-left shunt
through an atrial fenestration or venovenous collaterals
[8,9]. In our study fenestration was an open in 25% of pa-
tients. Wykretowicz et al [22] showed that in adult pa-
tients with cyanotic congenital heart diseases arterial
stiffness is affected by hematocrit concentration but not
SatO2. However, our study did not find such correlation It
should be noted that presented patients with cyanotic
congenital heart diseases had higher mean hematocrit
level (64%) than our Fontan patients.
Another factor that may affect the biophysical properties
of the aorta and therefore influence the wave reflection, ar-
terial pressure augmentation and contribute to central and
peripheral vascular dysfunction, is endothelial dysfunction.
We find elevated endothelial level in Fontan patients. Jin
et al. [23] has shown that the endothelial dysfunction is
more prevalent in Fontan patients compared with healthy
controls. Also the study of Natarajan et al. [24] which eval-
uated vascular function in patients with pre-Fontan single-
ventricle physiology reported an increased endothelin-1
level and decreased flow-mediated dilation.
Our study showed that also inflammation influenced
arterial stiffness in adult Fontan patients. We find correl-
ation between PWV and white blood cells and TNFα.
There is limited data regarding the relationship of in-
flammation with arterial stiffness in patients with single
ventricle. However, previous study demonstrated that in-
crease in systemic inflammation is an independent pre-
dictor of future development of hypertension [25]. The
increased vascular inflammation may increase vascular
fibrosis, cells proliferation, impaired endothelial which
lead to increased arterial stiffness [26]. The white blood
count is a simple and common test that was also proven
to be associated with stiffening of the arterial walls [27].
However all of the studies concerned population with
cardiovascular problems such as hypertension, diabetes
or coronary artery disease. It has been suggested that an
elevated white blood count, even within normal range, is
significantly associated with all cause, cardiovascular,
and cancer mortality [28]. We believe that this simple
test may be useful to determine the entirety condition of
the patient with Fontan circulation.
Liver is the organ at great risk after the Fontan oper-
ation [29]. Hepatic dysfunction caused by volume overload
and low cardiac output may result from a coexistence of
passive venous congestion of the liver, hypoxia, or con-
comitant pulmonary disease [30]. Noninvasive measures
of hepatic function include inter alia the measurements of
bilirubin, albumin, international normalized ratio. Most
patients with congenital heart disease and passive venous
congestion of the liver have elevated indirect bilirubin and
prolonged international normalized ratio with minimal el-
evations of the aminotransferases [31]. We have observedthe same results in our patients. Moreover, we have dem-
onstrated that these parameters remain in correlation with
noninvasive measurement of arterial stiffness. The associ-
ation of liver disease and increased arterial stiffness and
therefore elevated cardiovascular risk has been previously
shown in nondiabetic, nonhypertensive individuals [32]. It
has been postulated that screening tests that could identify
earlier stages of hepatic dysfunction development would
be of a great value, especially since currently used tests
are relatively insensitive [30]. The combination of blood
parameters of the hepatic function and noninvasive mea-
surements of arterial stiffness could be helpful in compre-
hensive care of patients with Fontan circulation.Study limitation
Several limitations of this study should be acknowledged.
The study group was small and heterogeneous with re-
gard to type of surgery. Also medication administrated
to the Fontan patients is not without an effect on the ar-
terial stiffness. The patients in our study were taking
medication such as ACE inhibitors - the drugs that de-
crease AIx [21]. This may suggest that the actual impact
of increased arterial stiffness may be underestimated.
However the patients did not take any medication on
the day of examination. Moreover, we did not deter-
mined single ventricle ejection fraction on magnetic res-
onance. However, previous studies. demonstrated similar
interobserver reproducibility for echocardiographic and
cardiac magnetic resonance assesment of single ventricle
function. Overall, the cardiac magnetic resonance data
were inadequate or incoplite in 30% of patients in whom
the test was performer, predominantly, due to metallic
artefacts [8,33,34].Conclusion
Adult Fontan patients have an increased arterial stiffness
assessed by noninvasive technique. Low arterial oxygen
saturation postoperative time, age at surgery and biliru-
bin level are associated with arterial stiffening in these
patients. The combination of blood parameters of the
hepatic function and noninvasive measurements of ar-
terial stiffness could be helpful in comprehensive care of
patients with Fontan circulation.
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